ArticleArthritis & rheumatology (Hoboken, N.J.)2026

Glucagon-Like Peptide-1 Receptor Agonist Therapy Is Associated With Improvement in Psoriatic Arthritis-Related and Metabolic Outcomes: A Retrospective Analysis of Two Cohorts.

Rebecca H Haberman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.